Cefoxitin as a Single-Dose Treatment for Urethritis Caused by Penicillinase-ProducingNeisseria Gonorrhoeae
- 6 September 1979
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 301 (10) , 509-511
- https://doi.org/10.1056/nejm197909063011001
Abstract
Gonococci that resist standard penicillin regimens by production of a penicillinase are now well established in certain areas of the world. Because cefoxitin, a semisynthetic cephamycin, resists gonococcal penicillinase in vitro, we compared procaine penicillin G and cefoxitin in treatment of gonorrhea in an area where 40 per cent of isolates produce penicillinase. One hundred and seven men with culture-proved gonococcal urethritis were given a single dose of either procaine penicillin G, 4.8 million U, or cefoxitin, 2 g, intramuscularly. Both groups took 1 g of probenecid orally; cefoxitin was given with lidocaine to reduce pain at the injection site.This publication has 8 references indexed in Scilit:
- Pharmacokinetics and Comparative Pharmacology of Cefoxitin and CephalosporinsClinical Infectious Diseases, 1979
- Treatment of Gonorrhea — Is Penicillin Passé?New England Journal of Medicine, 1977
- Plasmid-Mediated Beta-Lactamase Production in Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 1977
- Penicillinase-Producing Neisseria gonorrhoeaeSexually Transmitted Diseases, 1977
- The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeaeJournal of Antimicrobial Chemotherapy, 1976
- National Gonorrhea Therapy Monitoring StudyNew England Journal of Medicine, 1976
- Iodometric Detection of Haemophilus influenzae Beta-Lactamase: Rapid Presumptive Test for Ampicillin ResistanceAntimicrobial Agents and Chemotherapy, 1975